Tailoring immunosuppressive therapy based on donor and recipient risk factors.
First
M R
MR
University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0585, USA.
D000328:Adult; D001741:Black or African American; D044383:Black People; D002102:Cadaver; D002648:Child; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000145:classification* / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D016035:Pancreas Transplantation / Q000276:immunology / Q000502:physiology; D012307:Risk Factors; D014019:Tissue Donors; D014481:United States; D044465:White People
D007166:Immunosuppressive Agents